From: clsolu
Date: Jul  2 07:33:10 1996 (11 lines)
Subject: Clinical Trials

If you have chronic pain related to HIV or cancer, and are not satisfied with
opioid therapy (because of side effects or unrelieved pain) you may be
interested in a nation-wide clinical study of SNX-111, a neuron-specific
calcium channel blocker that is believed to relieve pain by interfering with
the neurotransmission of pain impulses. All study-related medical costs
include a 5-10 day hospital stay which will be covered. For more information
contact 1-800-57-STUDY ext. 99.
